MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...
The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
Cognitive biases impact how both patients and non-patients think about MS, says columnist Ben Hofmeister, who calls education the best remedy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback